John Lunger

Companies

• Adaptimmune (United Kingdom)Chief Patient Supply Officer Aug 5, 2019 to now¹
• Genocea (United States)Board member Mar 7, 2022 to Mar 7, 2022²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• AUAdaptimmune (United Kingdom) ADAPY7,510 shares³$176 at $0.02Jan 17, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 17, 2025Sold 5,584 shares at $0.58 of Adaptimmune (United Kingdom)³
• Jan 15, 2025Sold 9,803 shares at $0.57 of Adaptimmune (United Kingdom)⁴
• Jan 13, 2025Sold 5,471 shares at $0.59 of Adaptimmune (United Kingdom)⁴
• Jan 13, 2025Sold 4,268 shares at $0.59 of Adaptimmune (United Kingdom)⁴
• Jan 17, 2024Sold 12,805 shares at $0.67 of Adaptimmune (United Kingdom)⁵
• Jan 17, 2024Sold 5,309 shares at $0.67 of Adaptimmune (United Kingdom)⁵
• Jan 16, 2024Sold 4,681 shares at $0.79 of Adaptimmune (United Kingdom)⁵
• Jan 12, 2024Sold 5,220 shares at $0.85 of Adaptimmune (United Kingdom)⁶
• Jan 11, 2024Sold 4,009 shares at $0.84 of Adaptimmune (United Kingdom)⁶
• Aug 1, 2023Sold 3,096 shares at $0.91 of Adaptimmune (United Kingdom)⁷
• Jan 17, 2023Sold 4,440 shares at $1.86 of Adaptimmune (United Kingdom)⁸
• Jan 12, 2023Sold 4,973 shares at $1.71 of Adaptimmune (United Kingdom)⁹
• Jan 11, 2023Sold 3,843 shares at $1.75 of Adaptimmune (United Kingdom)⁹
• Jan 4, 2023Sold 1,100 shares at $1.69 of Adaptimmune (United Kingdom)¹⁰
• Aug 1, 2022Sold 2,983 shares at $1.77 of Adaptimmune (United Kingdom)¹¹
• Jul 5, 2022Sold 1,973 shares at $1.68 of Adaptimmune (United Kingdom)¹²
• Jan 18, 2022Sold 4,368 shares at $3.19 of Adaptimmune (United Kingdom)¹³
• Jan 12, 2022Sold 1,076 shares at $3.54 of Adaptimmune (United Kingdom)¹⁴
• Jan 11, 2022Sold 3,770 shares at $3.56 of Adaptimmune (United Kingdom)¹⁴
• Jan 4, 2022Sold 1,070 shares at $4.06 of Adaptimmune (United Kingdom)¹⁵